{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:43:13Z","timestamp":1774572193034,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.placenta.2020.02.014","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T02:34:57Z","timestamp":1582598097000},"page":"83-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Intrauterine growth restriction is associated with sex-specific alterations in the nitric oxide\/cyclic GMP relaxing pathway in the human umbilical vein"],"prefix":"10.1016","volume":"93","author":[{"given":"Manon","family":"Beaumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavien","family":"Delhaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steeve","family":"Men\u00e9trey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Joye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvan","family":"Vial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Baud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquier Goetschmann","family":"Magaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Tolsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Christine","family":"Peyter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00003081-200606000-00009","article-title":"Adult consequences of fetal growth restriction","volume":"49","author":"Barker","year":"2006","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.02.014_bib2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.1095292","article-title":"Living with the past: evolution, development, and patterns of disease","volume":"305","author":"Gluckman","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.placenta.2020.02.014_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.107.710715","article-title":"Perinatal risk factors for ischemic heart disease: disentangling the roles of birth weight and preterm birth","volume":"117","author":"Kaijser","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MOP.0b013e328326773b","article-title":"The developmental origins of adult disease","volume":"21","author":"Joss-Moore","year":"2009","journal-title":"Curr. Opin. Pediatr."},{"issue":"4","key":"10.1016\/j.placenta.2020.02.014_bib5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1017\/S2040174417000265","article-title":"Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches","volume":"8","author":"Yzydorczyk","year":"2017","journal-title":"J. Dev. Orig. Health Dis."},{"issue":"Suppl 3","key":"10.1016\/j.placenta.2020.02.014_bib6","first-page":"332","article-title":"Intrauterine growth retardation (IUGR): epidemiology and etiology","volume":"6","author":"Romo","year":"2009","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.placenta.2020.02.014_bib7","first-page":"66","article-title":"Prophylaxis and treatment of foetal growth restriction, Best practice & research","volume":"49","author":"Nawathe","year":"2018","journal-title":"Clin. Obstetr. Gynaecol."},{"issue":"3","key":"10.1016\/j.placenta.2020.02.014_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semperi.2008.02.002","article-title":"Diagnosis of IUGR: traditional biometry","volume":"32","author":"Platz","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.siny.2017.11.004","article-title":"Screening for fetal growth restriction and placental insufficiency","volume":"23","author":"Audette","year":"2018","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.placenta.2020.02.014_bib10","first-page":"48","article-title":"An integrated approach to fetal growth restriction, Best practice & research","volume":"38","author":"Figueras","year":"2017","journal-title":"Clin. Obstetr. Gynaecol."},{"key":"10.1016\/j.placenta.2020.02.014_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2020.02.014_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.semperi.2008.02.007","article-title":"Nutrient transport across the intrauterine growth-restricted placenta","volume":"32","author":"Marconi","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"Suppl A","key":"10.1016\/j.placenta.2020.02.014_bib13","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.placenta.2008.12.006","article-title":"Intrauterine growth restriction: implications for placental metabolism and transport. A review","volume":"30","author":"Cetin","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2020.02.014_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.semperi.2007.11.002","article-title":"The fetal response to chronic placental insufficiency","volume":"32","author":"Neerhof","year":"2008","journal-title":"Semin. Perinatol."},{"issue":"2S","key":"10.1016\/j.placenta.2020.02.014_bib15","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.ajog.2017.11.575","article-title":"A placenta clinic approach to the diagnosis and management of fetal growth restriction","volume":"218","author":"Kingdom","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.02.014_bib16","first-page":"37","article-title":"Physiological adaptation of the growth-restricted fetus, Best practice & research","volume":"49","author":"Marsal","year":"2018","journal-title":"Clin. Obstetr. Gynaecol."},{"issue":"1","key":"10.1016\/j.placenta.2020.02.014_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/pd.4254","article-title":"Functional echocardiography in the fetus with non-cardiac disease","volume":"34","author":"Van Mieghem","year":"2014","journal-title":"Prenat. Diagn."},{"issue":"17","key":"10.1016\/j.placenta.2020.02.014_bib18","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1113\/JP271745","article-title":"Programming of maternal and offspring disease: impact of growth restriction, fetal sex and transmission across generations","volume":"594","author":"Cheong","year":"2016","journal-title":"J. Physiol."},{"issue":"2S","key":"10.1016\/j.placenta.2020.02.014_bib19","doi-asserted-by":"crossref","first-page":"S869","DOI":"10.1016\/j.ajog.2017.12.012","article-title":"Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease","volume":"218","author":"Crispi","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"11","key":"10.1016\/j.placenta.2020.02.014_bib20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.placenta.2014.08.090","article-title":"Intrauterine growth restriction is associated with structural alterations in human umbilical cord and decreased nitric oxide-induced relaxation of umbilical vein","volume":"35","author":"Peyter","year":"2014","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.placenta.2020.02.014_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0046-8177(97)90251-3","article-title":"Computerized microscope morphometry of umbilical vessels from pregnancies with intrauterine growth retardation and abnormal umbilical artery Doppler","volume":"28","author":"Bruch","year":"1997","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.placenta.2020.02.014_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1469-0705.2000.00208.x","article-title":"Umbilical vein blood flow in growth-restricted fetuses","volume":"16","author":"Ferrazzi","year":"2000","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2020.02.014_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mob.2001.117356","article-title":"Early and persistent reduction in umbilical vein blood flow in the growth-restricted fetus: a longitudinal study","volume":"185","author":"Rigano","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.placenta.2020.02.014_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejrnm.2014.11.013","article-title":"Role of venous Doppler evaluation of intrauterine growth retardation","volume":"46","author":"AbdelMaboud","year":"2015","journal-title":"Egypt J. Radiol. Nucl. M"},{"key":"10.1016\/j.placenta.2020.02.014_bib25","series-title":"Fetal and Neonatal Physiology","first-page":"977","article-title":"Regulation of umbilical blood flow","author":"Adamson","year":"1998"},{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","article-title":"Vascular nitric oxide: beyond eNOS","volume":"129","author":"Zhao","year":"2015","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.placenta.2020.02.014_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/PL00005234","article-title":"Functional analysis of cGMP-dependent protein kinases I and II as mediators of NO\/cGMP effects","volume":"358","author":"Smolenski","year":"1998","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00018-011-0815-2","article-title":"Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle","volume":"69","author":"Morgado","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.placenta.2020.02.014_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.pa.36.040196.002155","article-title":"Cyclic nucleotide phosphodiesterases and vascular smooth muscle","volume":"36","author":"Polson","year":"1996","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.placenta.2020.02.014_bib30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.placenta.2020.02.014_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.placenta.2020.02.014_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.placenta.2020.02.014_bib33","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/odi.12275","article-title":"Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets","volume":"21","author":"Ahmad","year":"2015","journal-title":"Oral Dis."},{"key":"10.1016\/j.placenta.2020.02.014_bib34","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1055\/s-2006-924458","article-title":"Analyse des Neugeborenenkollectivs des Bundesrepublik Deutschland - 12. Mitteilung: vorstellung engmaschiger Perzentilwerte (-kurven) f\u00fcr die K\u00f6rpermasse Neugeborener","volume":"66","author":"Voigt","year":"2006","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.placenta.2020.02.014_bib35","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/AOG.0b013e31829ca9a7","article-title":"The role of growth trajectories in classifying fetal growth restriction","volume":"122","author":"Barker","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2020.02.014_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpeds.2017.12.059","article-title":"Consensus based definition of growth restriction in the newborn","volume":"196","author":"Beune","year":"2018","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-3565(25)10681-2","article-title":"Endothelin-1 modulates cyclic GMP production and relaxation in human pulmonary vessels","volume":"274","author":"Pussard","year":"1995","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.placenta.2020.02.014_bib38","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.placenta.2020.02.014_bib39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/1471-0528.15753","article-title":"Sildenafil therapy in early-onset fetal growth restriction: waiting for the individual patient data meta-analysis","volume":"126","author":"Figueras","year":"2019","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.placenta.2020.02.014_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/pds.4740","article-title":"Perinatal deaths after sildenafil treatment of fetal growth restriction raise the issue of safety in randomised clinical trials","volume":"28","author":"Lombardi","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.placenta.2020.02.014_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13063-018-3136-z","volume":"20","author":"Pels","year":"2019","journal-title":"Trials"},{"issue":"2S","key":"10.1016\/j.placenta.2020.02.014_bib42","doi-asserted-by":"crossref","first-page":"S829","DOI":"10.1016\/j.ajog.2017.11.565","article-title":"The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction","volume":"218","author":"Groom","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.placenta.2020.02.014_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045294","article-title":"Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction","volume":"7","author":"Pisaneschi","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.placenta.2020.02.014_bib44","doi-asserted-by":"crossref","first-page":"L201","DOI":"10.1152\/ajplung.00264.2007","article-title":"Muscarinic receptor M1 and phosphodiesterase 1 are key determinants in pulmonary vascular dysfunction following perinatal hypoxia in mice","volume":"295","author":"Peyter","year":"2008","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"5","key":"10.1016\/j.placenta.2020.02.014_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.vph.2006.08.002","article-title":"Nitric oxide and the endothelium: history and impact on cardiovascular disease","volume":"45","author":"Yetik-Anacak","year":"2006","journal-title":"Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.placenta.2020.02.014_bib46","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","article-title":"Gender, sex hormones, and vascular tone","volume":"286","author":"Orshal","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"7","key":"10.1016\/j.placenta.2020.02.014_bib47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCRESAHA.117.303776","article-title":"Contemporary approaches to modulating the nitric oxide-cGMP pathway in cardiovascular disease","volume":"120","author":"Kraehling","year":"2017","journal-title":"Circ. Res."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340042030062X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014340042030062X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:01:07Z","timestamp":1758909667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014340042030062X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":47,"alternative-id":["S014340042030062X"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2020.02.014","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intrauterine growth restriction is associated with sex-specific alterations in the nitric oxide\/cyclic GMP relaxing pathway in the human umbilical vein","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2020.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}